LevofloxacinAcquired drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2048卷 / 1期

关键词：

D O I：

10.1007/s40278-025-78443-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：223 / 223

相关论文

共 50 条

[31] PralsetinibAcquired drug resistance: case report
Reactions Weekly, 2022, 1927 (1) : 451 - 451
[32] GefitinibAcquired drug resistance: case report
Reactions Weekly, 2021, 1866 (1) : 187 - 187
[33] TemozolomideHypermutagenesis and drug resistance: case report
Reactions Weekly, 2021, 1851 (1) : 341 - 341
[34] InfliximabDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1847 (1) : 244 - 244
[35] BedaquilineEmergence of drug resistance: case report
Reactions Weekly, 2019, 1777 (1) : 52 - 52
[36] CrizotinibDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1882 (1) : 158 - 158
[37] CrizotinibDevelopment of drug resistance: case report
Reactions Weekly, 2018, 1705 (1) : 104 - 104
[38] EmicizumabDevelopment of drug resistance: case report
Reactions Weekly, 2022, 1888 (1) : 165 - 165
[39] ImatinibThrombocytopenia and drug resistance: case report
Reactions Weekly, 2010, 1310 (1) : 28 - 28
[40] BlinatumomabDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1847 (1) : 101 - 101

← 1 2 3 4 5 →